Logo
Give a Missed Call
+91 99532 12345
Logo
Give a Missed Call
+91 99532 12345
Login

Home

smallArrow

Stocks Screener

smallArrow

Natco Pharma Share Price

Natco Pharma Share Price

Natco Pharma (INR)1373.3-25.4   (-1.8%)

Exchange ScripsBSE524816NSENATCOPHARMISININE987B01026

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Natco Pharma Performance

Market performance
Open price1405.05
High1408.65
Volumes372991
Prev Close1373.3
Low1368.25
Closing date2024-10-21
Historical performance
1 Year High1639.00
3 Year High1639.00
5 Year High1639.00
1 Year Low724.20
3 Year Low502.00
5 Year Low402.55

Natco Pharma Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
24555
Face Value
Face Value (₹)
2
P/E Ratio
P/E Ratio
17.71
Dividend Yield
Dividend Yield
0.35 %

Natco Pharma Investment Returns

1 Year
67.1%
3 Years
59.7%
5 Years
141.8%
10 Years
419.9%

Natco Pharma Technicals

IndicatorsValueSignal
5-DMA1389.89Bearish
10-DMA1414.46Bearish
20-DMA1407.52Bearish
50-DMA1478.88Bearish
100-DMA1343.15Bullish
200-DMA1146.04Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters2121212121
Foreign Investors---------------
Domestic Investors2121212121
Public Investors302923251464228446207550163732
Government---1---------

Natco Pharma Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income128112859901060
Operating Profit187951040236257098
Interest192145177133
Depreciation1868163814261169
Profit Before Tax16735861920225796
Consolidated Net Profit13883715317004409
Adjusted EPS7839924

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital358365365365
Total Reserves58173483734223740676
Minority Interest---------18
Total Non-Current Liabilities610100513511429
Total Liabilities68869565745109147919
Capital Work in Progress137364312952234
Total Assets68869565745109147919

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities1211684914652988
Cash Flow from Investing Activities-10327-4771-53-1033
Cash Flow from Financing Activitie-2469-3630348-1857
Net Cash Inflow / Outflow-6809076098
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 17.71.
  • 3Y Stock Price CAGR of the stock is 17.8.
  • The stock has a beta of 0.6.
  • In the last financial year, the company had an EBITDA of ₹18795 Million.
  • The company generated revenue of ₹39988 Million in the previous financial year.

Natco Pharma

1373.3-25.4   (-1.8%)

Investment Amount: ₹ 80680
Current Value: ₹ 137330
Performence: 70.2%
P/L: ₹ 56650
Top Gainers
SymbolChange%
VHL5303.9(20%)
GFLLIMITED119.34(20%)
DIFFNKG408.3(20%)
SILINV877.1(20%)
PILANIINVS7536.05(20%)
Top Losers
SymbolChange%
PNCINFRA366.8(-20%)
INDIAMART2508.6(-17%)
RBLBANK176.14(-14%)
WABAG1710(-9%)
JMFINANCIL147.05(-7%)
MITCON107.19(-7%)
TATACONSUM1017.05(-7%)
AETHER862.6(-7%)
Similar stocks

Strides Pharma Scien

▲ 27.4

1638.55

September 21 - October 21

RPG Life Sciences

▲ 22.3

2749.85

September 21 - October 21

Jagsonpal Pharma

▲ 18.8

487.3

September 21 - October 21

Unichem Lab

▲ 17.3

757.95

September 21 - October 21

Windlas Biotech

▲ 14

1002.95

September 21 - October 21

Ipca Laboratories

▲ 12.5

1614.35

September 21 - October 21

Gufic Biosciences

▲ 10.9

450.15

September 21 - October 21

Medicamen Biotech

▲ 10.9

513.3

September 21 - October 21

Announcing Stock of the Month!

Stock of the Month
Stock of the Month